Alps Group Inc (“Alps”) is a biotechnology and life sciences organization headquartered in Malaysia. Through its subsidiaries, Alps operates across research and development, diagnostic testing, therapeutic development, and wellness services, focused on advancing precision, preventive and personalized medicine through innovations in genomics, mRNA technologies, and cellular therapy.
Alps owns and operates a GMP cell manufacturing lab, a molecular diagnostics lab, a medical centre, and a wellness centre, forming an integrated ecosystem for biotechnology research, healthcare delivery, and patient-centered wellness solutions creating a seamless bench to bedside continuum.
With a vision to transform global health outcomes, Alps is actively expanding its footprint through strategic partnerships and international collaborations. The company’s focus on scientific excellence, regulatory compliance, and patient-centered innovation drives its mission to deliver a ‘Fair Healthcare Ecosystem” through accessible, next-generation medical solutions across Southeast Asia and beyond.
New Chapter for a Revitalized Humanity
ALPS has a vision to create a new chapter by revitalizing life so that humanity can enjoy a refreshed and rejuvenated new life of good health and wellness.
Building a Collaborative Healthcare Ecosystem: Advancing Accessible and Affordable Medicine
Our mission is to foster a fair healthcare ecosystem. ALPS has taken steps to cultivate an ecosystem of collaboration among clinicians, stakeholders, and researchers who share our vision. Together, we are dedicated to expanding the range of diagnostic and treatment options available while simultaneously reducing costs, ensuring that cutting-edge medicine is more accessible.
Leveraging on our network comprising professional providers, suppliers, and supporting services, ALPS aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
ALPS possesses in-house laboratories capable of performing a range of genomic and cellular research, including WGS, Whole Exome Sequencing (WES), targeted sequencing, mRNA tests. ALPS also operates a cGMP accredited cell manufacturing laboratory. WGS, known as the most comprehensive clinical-grade DNA test available, provides invaluable insights into an individual’s inherited genetic predispositions. By unraveling the entire genetic makeup, this sequencing offers a wealth of information that can shape personalized medicine and enhance treatment efficacy.
In the realm of diagnostics and therapeutics, mRNA gene expression profiling is rapidly becoming a game-changer by acting as molecular biomarkers. These biomarkers are crucial for the early, accurate prediction and diagnosis of diseases, heralding a more proactive stance in healthcare management. mRNA tests provide a window into gene expression changes as they occur, facilitating prompt medical interventions to preempt disease progression.
ALPS is committed to integrate WGS and mRNA expression profiling into routine diagnostic practices and to forge new paths in personalized medicine. Looking ahead, we aim to further enhance our service offerings by integrating the production and cultivation of autologous stem cells directly within our facilities. Additionally, we intend to establish an international research and development hub, collaborating with renowned scientists and institutions to advance cellular therapy as therapeutic entities.
The Group commenced business in 1994 when Dr. THAM Seng Kong started his private practice. Celebre Pro Medic Sdn Bhd was established soon after to provide advanced stem cell therapy products developed by a reputable Swiss laboratory that is one of the pioneers and global leader in biomedical products, with direct access to all their state-of-the-art resources and Research & Development facilities.
The key driving force behind ALPS is the founder, Dr. THAM an established member of the Malaysian Society for Stem Cell Research & Theraphy (MSCRT) and the Malaysia Association for Cell Therapy (MACT) in Malaysia. He is a veteran in the field of life sciences, with a genuine passion for the field of Cellular Therapy. Dr. THAM earned his Bachelor of Medicine from Xiamen University, Doctor of Medicine (MD) Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) and Doctor of Medicine (MD) in Biomedical Engineering. Presently he has the privilege of treating and consulting international members of royalty, celebrities, and members of the elite. A well sought-after Educator on Best Practices, he also dedicates his time between clinical physicians and members of the public.